Michael Dey
Keine laufenden Positionen mehr
Profil
Michael Dey served as the President of ESI Lederle and Wyeth LLC.
He was also the CEO and Director of Predictive Therapeutics LLC and a Director at Juneau Biosciences LLC.
Dey was an Independent Director at Predictive Technology Group, Inc. He earned an undergraduate degree from the University of Washington, a graduate degree from the University of California, Davis, and a doctorate from Washington State University.
He also earned an undergraduate degree from Western Washington University.
Ehemalige bekannte Positionen von Michael Dey
| Unternehmen | Position | Ende |
|---|---|---|
| PREDICTIVE TECHNOLOGY GROUP, INC. | Director/Board Member | 01.04.2023 |
Juneau Biosciences LLC
 Juneau Biosciences LLC Medical SpecialtiesHealth Technology Juneau Biosciences LLC develops and commercializes novel diagnostic and therapeutic products focused on women's health care. It is a molecular genetics company. The company was founded by Kenneth Ward in 2007 and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
ESI Lederle
 ESI Lederle Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., ESI Lederle is a private company that manufactures and distributes injectable drugs. The company is based in Cherry Hill, NJ. ESI Lederle was acquired by Baxter Healthcare Corp. from Wyeth LLC on December 20, 2002 for $305 million. | President | - |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Predictive Therapeutics LLC
 Predictive Therapeutics LLC BiotechnologyHealth Technology Predictive Therapeutics LLC specializes in the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. It develops, commercializes, acquires, and invests in technologies involved in novel molecular diagnostic and therapeutic healthcare products. The company is headquartered in Salt Lake City, UT. | Chief Executive Officer | - |
Ausbildung von Michael Dey
| University of Washington | Undergraduate Degree |
| University of California, Davis | Graduate Degree |
| Washington State University | Doctorate Degree |
| Western Washington University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PREDICTIVE TECHNOLOGY GROUP, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Juneau Biosciences LLC
Juneau Biosciences LLC Medical SpecialtiesHealth Technology Juneau Biosciences LLC develops and commercializes novel diagnostic and therapeutic products focused on women's health care. It is a molecular genetics company. The company was founded by Kenneth Ward in 2007 and is headquartered in Salt Lake City, UT. | Health Technology |
ESI Lederle
ESI Lederle Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., ESI Lederle is a private company that manufactures and distributes injectable drugs. The company is based in Cherry Hill, NJ. ESI Lederle was acquired by Baxter Healthcare Corp. from Wyeth LLC on December 20, 2002 for $305 million. | Health Technology |
Predictive Therapeutics LLC
Predictive Therapeutics LLC BiotechnologyHealth Technology Predictive Therapeutics LLC specializes in the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. It develops, commercializes, acquires, and invests in technologies involved in novel molecular diagnostic and therapeutic healthcare products. The company is headquartered in Salt Lake City, UT. | Health Technology |
